nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—CYP2D6—Lomustine—hematologic cancer	0.0971	0.189	CbGbCtD
Carteolol—CYP2D6—Idarubicin—hematologic cancer	0.0866	0.168	CbGbCtD
Carteolol—CYP2D6—Hydroxyurea—hematologic cancer	0.0736	0.143	CbGbCtD
Carteolol—CYP2D6—Bortezomib—hematologic cancer	0.064	0.124	CbGbCtD
Carteolol—CYP2D6—Imatinib—hematologic cancer	0.0469	0.0912	CbGbCtD
Carteolol—CYP2D6—Nilotinib—hematologic cancer	0.0426	0.0829	CbGbCtD
Carteolol—CYP2D6—Vinorelbine—hematologic cancer	0.0423	0.0822	CbGbCtD
Carteolol—CYP2D6—Vinblastine—hematologic cancer	0.0261	0.0506	CbGbCtD
Carteolol—CYP2D6—Dexamethasone—hematologic cancer	0.0193	0.0375	CbGbCtD
Carteolol—CYP2D6—Doxorubicin—hematologic cancer	0.016	0.0311	CbGbCtD
Carteolol—Arrhythmia—Prednisolone—hematologic cancer	0.000328	0.000768	CcSEcCtD
Carteolol—Dizziness—Nilotinib—hematologic cancer	0.000327	0.000767	CcSEcCtD
Carteolol—Oedema—Vincristine—hematologic cancer	0.000326	0.000764	CcSEcCtD
Carteolol—Dizziness—Imatinib—hematologic cancer	0.000325	0.000762	CcSEcCtD
Carteolol—Hypersensitivity—Melphalan—hematologic cancer	0.000325	0.000761	CcSEcCtD
Carteolol—Nausea—Procarbazine—hematologic cancer	0.000324	0.00076	CcSEcCtD
Carteolol—Insomnia—Thalidomide—hematologic cancer	0.000322	0.000754	CcSEcCtD
Carteolol—Diabetes mellitus—Doxorubicin—hematologic cancer	0.000321	0.000751	CcSEcCtD
Carteolol—Dizziness—Cladribine—hematologic cancer	0.00032	0.000749	CcSEcCtD
Carteolol—Hypotension—Carmustine—hematologic cancer	0.000319	0.000748	CcSEcCtD
Carteolol—Nausea—Bexarotene—hematologic cancer	0.000318	0.000745	CcSEcCtD
Carteolol—Nausea—Dasatinib—hematologic cancer	0.000318	0.000745	CcSEcCtD
Carteolol—Oedema—Mitoxantrone—hematologic cancer	0.000318	0.000744	CcSEcCtD
Carteolol—Oedema—Irinotecan—hematologic cancer	0.000318	0.000744	CcSEcCtD
Carteolol—Dyspnoea—Thalidomide—hematologic cancer	0.000317	0.000743	CcSEcCtD
Carteolol—Nausea—Fludarabine—hematologic cancer	0.000317	0.000743	CcSEcCtD
Carteolol—Dysgeusia—Etoposide—hematologic cancer	0.000317	0.000743	CcSEcCtD
Carteolol—Asthenia—Melphalan—hematologic cancer	0.000316	0.000741	CcSEcCtD
Carteolol—Hypotension—Alitretinoin—hematologic cancer	0.000316	0.000741	CcSEcCtD
Carteolol—Hypersensitivity—Lenalidomide—hematologic cancer	0.000316	0.00074	CcSEcCtD
Carteolol—Hypotension—Ifosfamide—hematologic cancer	0.000313	0.000733	CcSEcCtD
Carteolol—Shock—Mitoxantrone—hematologic cancer	0.000313	0.000732	CcSEcCtD
Carteolol—Shock—Irinotecan—hematologic cancer	0.000313	0.000732	CcSEcCtD
Carteolol—Bradycardia—Dexamethasone—hematologic cancer	0.000312	0.00073	CcSEcCtD
Carteolol—Bradycardia—Betamethasone—hematologic cancer	0.000312	0.00073	CcSEcCtD
Carteolol—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000311	0.00073	CcSEcCtD
Carteolol—Headache—Nilotinib—hematologic cancer	0.00031	0.000726	CcSEcCtD
Carteolol—Oedema—Gemcitabine—hematologic cancer	0.000309	0.000725	CcSEcCtD
Carteolol—Insomnia—Carmustine—hematologic cancer	0.000309	0.000724	CcSEcCtD
Carteolol—Hypoglycaemia—Epirubicin—hematologic cancer	0.000309	0.000724	CcSEcCtD
Carteolol—Headache—Imatinib—hematologic cancer	0.000308	0.000722	CcSEcCtD
Carteolol—Asthenia—Lenalidomide—hematologic cancer	0.000308	0.000721	CcSEcCtD
Carteolol—Cerebrovascular accident—Epirubicin—hematologic cancer	0.000308	0.000721	CcSEcCtD
Carteolol—Cardiac failure congestive—Doxorubicin—hematologic cancer	0.000308	0.000721	CcSEcCtD
Carteolol—Dizziness—Vinblastine—hematologic cancer	0.000307	0.000718	CcSEcCtD
Carteolol—Insomnia—Alitretinoin—hematologic cancer	0.000306	0.000717	CcSEcCtD
Carteolol—Hypotension—Vincristine—hematologic cancer	0.000305	0.000714	CcSEcCtD
Carteolol—Dyspnoea—Carmustine—hematologic cancer	0.000305	0.000714	CcSEcCtD
Carteolol—Asthenia—Hydroxyurea—hematologic cancer	0.000303	0.000711	CcSEcCtD
Carteolol—Headache—Cladribine—hematologic cancer	0.000303	0.00071	CcSEcCtD
Carteolol—Dyspnoea—Alitretinoin—hematologic cancer	0.000302	0.000707	CcSEcCtD
Carteolol—Diplopia—Epirubicin—hematologic cancer	0.000301	0.000706	CcSEcCtD
Carteolol—Arrhythmia—Triamcinolone—hematologic cancer	0.000301	0.000706	CcSEcCtD
Carteolol—Vision blurred—Prednisolone—hematologic cancer	0.000301	0.000705	CcSEcCtD
Carteolol—Nausea—Chlorambucil—hematologic cancer	0.0003	0.000704	CcSEcCtD
Carteolol—Dyspnoea—Ifosfamide—hematologic cancer	0.000298	0.000699	CcSEcCtD
Carteolol—Hypotension—Irinotecan—hematologic cancer	0.000297	0.000696	CcSEcCtD
Carteolol—Hypotension—Mitoxantrone—hematologic cancer	0.000297	0.000696	CcSEcCtD
Carteolol—Depression—Prednisone—hematologic cancer	0.000296	0.000694	CcSEcCtD
Carteolol—Insomnia—Vincristine—hematologic cancer	0.000295	0.000691	CcSEcCtD
Carteolol—Visual impairment—Betamethasone—hematologic cancer	0.000295	0.000691	CcSEcCtD
Carteolol—Visual impairment—Dexamethasone—hematologic cancer	0.000295	0.000691	CcSEcCtD
Carteolol—Nausea—Nilotinib—hematologic cancer	0.000294	0.000689	CcSEcCtD
Carteolol—Nausea—Imatinib—hematologic cancer	0.000292	0.000685	CcSEcCtD
Carteolol—Hypersensitivity—Bortezomib—hematologic cancer	0.000291	0.000681	CcSEcCtD
Carteolol—Headache—Vinblastine—hematologic cancer	0.00029	0.00068	CcSEcCtD
Carteolol—Hypotension—Gemcitabine—hematologic cancer	0.000289	0.000678	CcSEcCtD
Carteolol—Oedema—Cisplatin—hematologic cancer	0.000288	0.000676	CcSEcCtD
Carteolol—Hypersensitivity—Bleomycin—hematologic cancer	0.000288	0.000676	CcSEcCtD
Carteolol—Dysgeusia—Triamcinolone—hematologic cancer	0.000288	0.000674	CcSEcCtD
Carteolol—Insomnia—Irinotecan—hematologic cancer	0.000287	0.000673	CcSEcCtD
Carteolol—Nausea—Cladribine—hematologic cancer	0.000287	0.000673	CcSEcCtD
Carteolol—Syncope—Prednisolone—hematologic cancer	0.000286	0.000671	CcSEcCtD
Carteolol—Hypoglycaemia—Doxorubicin—hematologic cancer	0.000286	0.00067	CcSEcCtD
Carteolol—Loss of consciousness—Etoposide—hematologic cancer	0.000285	0.000667	CcSEcCtD
Carteolol—Cerebrovascular accident—Doxorubicin—hematologic cancer	0.000285	0.000667	CcSEcCtD
Carteolol—Hypersensitivity—Vinorelbine—hematologic cancer	0.000284	0.000665	CcSEcCtD
Carteolol—Dizziness—Lenalidomide—hematologic cancer	0.000284	0.000664	CcSEcCtD
Carteolol—Dyspnoea—Mitoxantrone—hematologic cancer	0.000283	0.000664	CcSEcCtD
Carteolol—Dyspnoea—Irinotecan—hematologic cancer	0.000283	0.000664	CcSEcCtD
Carteolol—Asthenia—Bortezomib—hematologic cancer	0.000283	0.000663	CcSEcCtD
Carteolol—Asthenia—Bleomycin—hematologic cancer	0.000281	0.000658	CcSEcCtD
Carteolol—Loss of consciousness—Prednisolone—hematologic cancer	0.000281	0.000658	CcSEcCtD
Carteolol—Insomnia—Gemcitabine—hematologic cancer	0.00028	0.000656	CcSEcCtD
Carteolol—Dizziness—Hydroxyurea—hematologic cancer	0.00028	0.000655	CcSEcCtD
Carteolol—Diplopia—Doxorubicin—hematologic cancer	0.000279	0.000653	CcSEcCtD
Carteolol—Asthenia—Vinorelbine—hematologic cancer	0.000276	0.000648	CcSEcCtD
Carteolol—Dyspnoea—Gemcitabine—hematologic cancer	0.000276	0.000646	CcSEcCtD
Carteolol—Nausea—Vinblastine—hematologic cancer	0.000275	0.000645	CcSEcCtD
Carteolol—Arrhythmia—Betamethasone—hematologic cancer	0.000273	0.000641	CcSEcCtD
Carteolol—Arrhythmia—Dexamethasone—hematologic cancer	0.000273	0.000641	CcSEcCtD
Carteolol—Bradycardia—Prednisone—hematologic cancer	0.000271	0.000636	CcSEcCtD
Carteolol—Hypersensitivity—Thiotepa—hematologic cancer	0.000271	0.000635	CcSEcCtD
Carteolol—Hypotension—Cisplatin—hematologic cancer	0.00027	0.000632	CcSEcCtD
Carteolol—Headache—Lenalidomide—hematologic cancer	0.000269	0.000629	CcSEcCtD
Carteolol—Headache—Hydroxyurea—hematologic cancer	0.000265	0.000621	CcSEcCtD
Carteolol—Asthenia—Thiotepa—hematologic cancer	0.000264	0.000618	CcSEcCtD
Carteolol—Syncope—Triamcinolone—hematologic cancer	0.000263	0.000617	CcSEcCtD
Carteolol—Hypersensitivity—Thalidomide—hematologic cancer	0.000262	0.000614	CcSEcCtD
Carteolol—Nausea—Melphalan—hematologic cancer	0.000262	0.000614	CcSEcCtD
Carteolol—Dizziness—Bortezomib—hematologic cancer	0.000261	0.000611	CcSEcCtD
Carteolol—Oedema—Prednisolone—hematologic cancer	0.000261	0.000611	CcSEcCtD
Carteolol—Loss of consciousness—Triamcinolone—hematologic cancer	0.000258	0.000605	CcSEcCtD
Carteolol—Dyspnoea—Cisplatin—hematologic cancer	0.000257	0.000603	CcSEcCtD
Carteolol—Shock—Prednisolone—hematologic cancer	0.000256	0.000601	CcSEcCtD
Carteolol—Asthenia—Thalidomide—hematologic cancer	0.000255	0.000598	CcSEcCtD
Carteolol—Dizziness—Vinorelbine—hematologic cancer	0.000255	0.000597	CcSEcCtD
Carteolol—Nausea—Lenalidomide—hematologic cancer	0.000255	0.000597	CcSEcCtD
Carteolol—Hypersensitivity—Carmustine—hematologic cancer	0.000252	0.00059	CcSEcCtD
Carteolol—Nausea—Hydroxyurea—hematologic cancer	0.000251	0.000588	CcSEcCtD
Carteolol—Hypersensitivity—Alitretinoin—hematologic cancer	0.000249	0.000584	CcSEcCtD
Carteolol—Depression—Methotrexate—hematologic cancer	0.000247	0.00058	CcSEcCtD
Carteolol—Headache—Bortezomib—hematologic cancer	0.000247	0.000579	CcSEcCtD
Carteolol—Hypotension—Etoposide—hematologic cancer	0.000247	0.000579	CcSEcCtD
Carteolol—Hypersensitivity—Ifosfamide—hematologic cancer	0.000247	0.000578	CcSEcCtD
Carteolol—Asthenia—Carmustine—hematologic cancer	0.000245	0.000575	CcSEcCtD
Carteolol—Dizziness—Thiotepa—hematologic cancer	0.000243	0.00057	CcSEcCtD
Carteolol—Asthenia—Alitretinoin—hematologic cancer	0.000243	0.000569	CcSEcCtD
Carteolol—Headache—Vinorelbine—hematologic cancer	0.000241	0.000565	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—hematologic cancer	0.000241	0.000565	CcSEcCtD
Carteolol—Hypersensitivity—Vincristine—hematologic cancer	0.00024	0.000563	CcSEcCtD
Carteolol—Asthenia—Ifosfamide—hematologic cancer	0.00024	0.000563	CcSEcCtD
Carteolol—Oedema—Triamcinolone—hematologic cancer	0.00024	0.000562	CcSEcCtD
Carteolol—Syncope—Dexamethasone—hematologic cancer	0.000239	0.00056	CcSEcCtD
Carteolol—Syncope—Betamethasone—hematologic cancer	0.000239	0.00056	CcSEcCtD
Carteolol—Arrhythmia—Prednisone—hematologic cancer	0.000238	0.000558	CcSEcCtD
Carteolol—Shock—Triamcinolone—hematologic cancer	0.000236	0.000553	CcSEcCtD
Carteolol—Insomnia—Prednisolone—hematologic cancer	0.000236	0.000552	CcSEcCtD
Carteolol—Dyspnoea—Etoposide—hematologic cancer	0.000236	0.000552	CcSEcCtD
Carteolol—Dizziness—Thalidomide—hematologic cancer	0.000235	0.000551	CcSEcCtD
Carteolol—Nausea—Bortezomib—hematologic cancer	0.000234	0.000549	CcSEcCtD
Carteolol—Loss of consciousness—Betamethasone—hematologic cancer	0.000234	0.000549	CcSEcCtD
Carteolol—Loss of consciousness—Dexamethasone—hematologic cancer	0.000234	0.000549	CcSEcCtD
Carteolol—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000234	0.000548	CcSEcCtD
Carteolol—Hypersensitivity—Irinotecan—hematologic cancer	0.000234	0.000548	CcSEcCtD
Carteolol—Asthenia—Vincristine—hematologic cancer	0.000234	0.000548	CcSEcCtD
Carteolol—Nausea—Bleomycin—hematologic cancer	0.000233	0.000545	CcSEcCtD
Carteolol—Headache—Thiotepa—hematologic cancer	0.00023	0.00054	CcSEcCtD
Carteolol—Nausea—Vinorelbine—hematologic cancer	0.000229	0.000536	CcSEcCtD
Carteolol—Asthenia—Irinotecan—hematologic cancer	0.000228	0.000534	CcSEcCtD
Carteolol—Asthenia—Mitoxantrone—hematologic cancer	0.000228	0.000534	CcSEcCtD
Carteolol—Dizziness—Carmustine—hematologic cancer	0.000226	0.00053	CcSEcCtD
Carteolol—Conjunctivitis—Epirubicin—hematologic cancer	0.000226	0.000529	CcSEcCtD
Carteolol—Dizziness—Alitretinoin—hematologic cancer	0.000224	0.000525	CcSEcCtD
Carteolol—Headache—Thalidomide—hematologic cancer	0.000223	0.000522	CcSEcCtD
Carteolol—Asthenia—Gemcitabine—hematologic cancer	0.000222	0.00052	CcSEcCtD
Carteolol—Dizziness—Ifosfamide—hematologic cancer	0.000221	0.000518	CcSEcCtD
Carteolol—Vision blurred—Prednisone—hematologic cancer	0.000219	0.000512	CcSEcCtD
Carteolol—Nausea—Thiotepa—hematologic cancer	0.000219	0.000512	CcSEcCtD
Carteolol—Sinusitis—Epirubicin—hematologic cancer	0.000218	0.000511	CcSEcCtD
Carteolol—Oedema—Betamethasone—hematologic cancer	0.000217	0.00051	CcSEcCtD
Carteolol—Oedema—Dexamethasone—hematologic cancer	0.000217	0.00051	CcSEcCtD
Carteolol—Insomnia—Triamcinolone—hematologic cancer	0.000217	0.000508	CcSEcCtD
Carteolol—Dizziness—Vincristine—hematologic cancer	0.000216	0.000505	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—hematologic cancer	0.000215	0.000503	CcSEcCtD
Carteolol—Headache—Carmustine—hematologic cancer	0.000214	0.000502	CcSEcCtD
Carteolol—Shock—Betamethasone—hematologic cancer	0.000214	0.000501	CcSEcCtD
Carteolol—Shock—Dexamethasone—hematologic cancer	0.000214	0.000501	CcSEcCtD
Carteolol—Dyspnoea—Triamcinolone—hematologic cancer	0.000214	0.000501	CcSEcCtD
Carteolol—Hypersensitivity—Cisplatin—hematologic cancer	0.000213	0.000498	CcSEcCtD
Carteolol—Bradycardia—Epirubicin—hematologic cancer	0.000212	0.000497	CcSEcCtD
Carteolol—Headache—Alitretinoin—hematologic cancer	0.000212	0.000497	CcSEcCtD
Carteolol—Nausea—Thalidomide—hematologic cancer	0.000211	0.000495	CcSEcCtD
Carteolol—Dizziness—Irinotecan—hematologic cancer	0.00021	0.000492	CcSEcCtD
Carteolol—Conjunctivitis—Doxorubicin—hematologic cancer	0.000209	0.000489	CcSEcCtD
Carteolol—Syncope—Prednisone—hematologic cancer	0.000208	0.000488	CcSEcCtD
Carteolol—Asthenia—Cisplatin—hematologic cancer	0.000207	0.000485	CcSEcCtD
Carteolol—Headache—Vincristine—hematologic cancer	0.000204	0.000479	CcSEcCtD
Carteolol—Loss of consciousness—Prednisone—hematologic cancer	0.000204	0.000478	CcSEcCtD
Carteolol—Hypotension—Betamethasone—hematologic cancer	0.000203	0.000476	CcSEcCtD
Carteolol—Hypotension—Dexamethasone—hematologic cancer	0.000203	0.000476	CcSEcCtD
Carteolol—Nausea—Carmustine—hematologic cancer	0.000203	0.000476	CcSEcCtD
Carteolol—Sinusitis—Doxorubicin—hematologic cancer	0.000202	0.000472	CcSEcCtD
Carteolol—Nausea—Alitretinoin—hematologic cancer	0.000201	0.000471	CcSEcCtD
Carteolol—Visual impairment—Epirubicin—hematologic cancer	0.000201	0.000471	CcSEcCtD
Carteolol—Headache—Mitoxantrone—hematologic cancer	0.000199	0.000466	CcSEcCtD
Carteolol—Headache—Irinotecan—hematologic cancer	0.000199	0.000466	CcSEcCtD
Carteolol—Nausea—Ifosfamide—hematologic cancer	0.000199	0.000466	CcSEcCtD
Carteolol—Insomnia—Dexamethasone—hematologic cancer	0.000197	0.000461	CcSEcCtD
Carteolol—Insomnia—Betamethasone—hematologic cancer	0.000197	0.000461	CcSEcCtD
Carteolol—Bradycardia—Doxorubicin—hematologic cancer	0.000196	0.00046	CcSEcCtD
Carteolol—Hypersensitivity—Etoposide—hematologic cancer	0.000195	0.000456	CcSEcCtD
Carteolol—Headache—Gemcitabine—hematologic cancer	0.000194	0.000454	CcSEcCtD
Carteolol—Nausea—Vincristine—hematologic cancer	0.000194	0.000454	CcSEcCtD
Carteolol—Hypersensitivity—Prednisolone—hematologic cancer	0.000192	0.00045	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—hematologic cancer	0.00019	0.000445	CcSEcCtD
Carteolol—Asthenia—Etoposide—hematologic cancer	0.00019	0.000444	CcSEcCtD
Carteolol—Oedema—Prednisone—hematologic cancer	0.000189	0.000444	CcSEcCtD
Carteolol—Nausea—Irinotecan—hematologic cancer	0.000189	0.000442	CcSEcCtD
Carteolol—Nausea—Mitoxantrone—hematologic cancer	0.000189	0.000442	CcSEcCtD
Carteolol—Shock—Prednisone—hematologic cancer	0.000186	0.000437	CcSEcCtD
Carteolol—Arrhythmia—Epirubicin—hematologic cancer	0.000186	0.000436	CcSEcCtD
Carteolol—Visual impairment—Doxorubicin—hematologic cancer	0.000186	0.000436	CcSEcCtD
Carteolol—Nausea—Gemcitabine—hematologic cancer	0.000184	0.000431	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—hematologic cancer	0.000183	0.000428	CcSEcCtD
Carteolol—Dysgeusia—Epirubicin—hematologic cancer	0.000178	0.000416	CcSEcCtD
Carteolol—Hypersensitivity—Triamcinolone—hematologic cancer	0.000177	0.000414	CcSEcCtD
Carteolol—Dizziness—Etoposide—hematologic cancer	0.000175	0.000409	CcSEcCtD
Carteolol—Dizziness—Prednisolone—hematologic cancer	0.000172	0.000404	CcSEcCtD
Carteolol—Arrhythmia—Doxorubicin—hematologic cancer	0.000172	0.000404	CcSEcCtD
Carteolol—Asthenia—Triamcinolone—hematologic cancer	0.000172	0.000403	CcSEcCtD
Carteolol—Nausea—Cisplatin—hematologic cancer	0.000171	0.000401	CcSEcCtD
Carteolol—Insomnia—Prednisone—hematologic cancer	0.000171	0.000401	CcSEcCtD
Carteolol—Vision blurred—Epirubicin—hematologic cancer	0.000171	0.000401	CcSEcCtD
Carteolol—Headache—Etoposide—hematologic cancer	0.000166	0.000388	CcSEcCtD
Carteolol—Dysgeusia—Doxorubicin—hematologic cancer	0.000164	0.000385	CcSEcCtD
Carteolol—Headache—Prednisolone—hematologic cancer	0.000163	0.000383	CcSEcCtD
Carteolol—Syncope—Epirubicin—hematologic cancer	0.000163	0.000381	CcSEcCtD
Carteolol—Palpitations—Epirubicin—hematologic cancer	0.00016	0.000376	CcSEcCtD
Carteolol—Loss of consciousness—Epirubicin—hematologic cancer	0.00016	0.000374	CcSEcCtD
Carteolol—Dizziness—Triamcinolone—hematologic cancer	0.000159	0.000371	CcSEcCtD
Carteolol—Vision blurred—Doxorubicin—hematologic cancer	0.000158	0.000371	CcSEcCtD
Carteolol—Nausea—Etoposide—hematologic cancer	0.000157	0.000368	CcSEcCtD
Carteolol—Asthenia—Dexamethasone—hematologic cancer	0.000156	0.000366	CcSEcCtD
Carteolol—Asthenia—Betamethasone—hematologic cancer	0.000156	0.000366	CcSEcCtD
Carteolol—Nausea—Prednisolone—hematologic cancer	0.000155	0.000363	CcSEcCtD
Carteolol—Syncope—Doxorubicin—hematologic cancer	0.000151	0.000353	CcSEcCtD
Carteolol—Headache—Triamcinolone—hematologic cancer	0.00015	0.000352	CcSEcCtD
Carteolol—Palpitations—Doxorubicin—hematologic cancer	0.000148	0.000348	CcSEcCtD
Carteolol—Oedema—Epirubicin—hematologic cancer	0.000148	0.000347	CcSEcCtD
Carteolol—Hypotension—Methotrexate—hematologic cancer	0.000148	0.000347	CcSEcCtD
Carteolol—Loss of consciousness—Doxorubicin—hematologic cancer	0.000148	0.000346	CcSEcCtD
Carteolol—Shock—Epirubicin—hematologic cancer	0.000146	0.000341	CcSEcCtD
Carteolol—Dizziness—Betamethasone—hematologic cancer	0.000144	0.000337	CcSEcCtD
Carteolol—Dizziness—Dexamethasone—hematologic cancer	0.000144	0.000337	CcSEcCtD
Carteolol—Insomnia—Methotrexate—hematologic cancer	0.000143	0.000335	CcSEcCtD
Carteolol—Nausea—Triamcinolone—hematologic cancer	0.000142	0.000334	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—hematologic cancer	0.000141	0.000331	CcSEcCtD
Carteolol—Hypersensitivity—Prednisone—hematologic cancer	0.00014	0.000327	CcSEcCtD
Carteolol—Hypotension—Epirubicin—hematologic cancer	0.000138	0.000324	CcSEcCtD
Carteolol—Oedema—Doxorubicin—hematologic cancer	0.000137	0.000321	CcSEcCtD
Carteolol—Headache—Dexamethasone—hematologic cancer	0.000136	0.000319	CcSEcCtD
Carteolol—Headache—Betamethasone—hematologic cancer	0.000136	0.000319	CcSEcCtD
Carteolol—Asthenia—Prednisone—hematologic cancer	0.000136	0.000318	CcSEcCtD
Carteolol—Shock—Doxorubicin—hematologic cancer	0.000135	0.000316	CcSEcCtD
Carteolol—Insomnia—Epirubicin—hematologic cancer	0.000134	0.000314	CcSEcCtD
Carteolol—Dyspnoea—Epirubicin—hematologic cancer	0.000132	0.000309	CcSEcCtD
Carteolol—Nausea—Betamethasone—hematologic cancer	0.000129	0.000303	CcSEcCtD
Carteolol—Nausea—Dexamethasone—hematologic cancer	0.000129	0.000303	CcSEcCtD
Carteolol—Hypotension—Doxorubicin—hematologic cancer	0.000128	0.0003	CcSEcCtD
Carteolol—Dizziness—Prednisone—hematologic cancer	0.000125	0.000293	CcSEcCtD
Carteolol—Insomnia—Doxorubicin—hematologic cancer	0.000124	0.00029	CcSEcCtD
Carteolol—Dyspnoea—Doxorubicin—hematologic cancer	0.000122	0.000286	CcSEcCtD
Carteolol—Headache—Prednisone—hematologic cancer	0.000119	0.000278	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—hematologic cancer	0.000117	0.000273	CcSEcCtD
Carteolol—Asthenia—Methotrexate—hematologic cancer	0.000114	0.000266	CcSEcCtD
Carteolol—Nausea—Prednisone—hematologic cancer	0.000113	0.000264	CcSEcCtD
Carteolol—Hypersensitivity—Epirubicin—hematologic cancer	0.000109	0.000256	CcSEcCtD
Carteolol—Asthenia—Epirubicin—hematologic cancer	0.000106	0.000249	CcSEcCtD
Carteolol—Dizziness—Methotrexate—hematologic cancer	0.000105	0.000245	CcSEcCtD
Carteolol—Hypersensitivity—Doxorubicin—hematologic cancer	0.000101	0.000237	CcSEcCtD
Carteolol—Headache—Methotrexate—hematologic cancer	9.92e-05	0.000232	CcSEcCtD
Carteolol—Asthenia—Doxorubicin—hematologic cancer	9.83e-05	0.00023	CcSEcCtD
Carteolol—Dizziness—Epirubicin—hematologic cancer	9.8e-05	0.00023	CcSEcCtD
Carteolol—Nausea—Methotrexate—hematologic cancer	9.4e-05	0.00022	CcSEcCtD
Carteolol—Headache—Epirubicin—hematologic cancer	9.28e-05	0.000217	CcSEcCtD
Carteolol—Dizziness—Doxorubicin—hematologic cancer	9.06e-05	0.000212	CcSEcCtD
Carteolol—Nausea—Epirubicin—hematologic cancer	8.8e-05	0.000206	CcSEcCtD
Carteolol—Headache—Doxorubicin—hematologic cancer	8.59e-05	0.000201	CcSEcCtD
Carteolol—Nausea—Doxorubicin—hematologic cancer	8.14e-05	0.000191	CcSEcCtD
Carteolol—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	2.39e-05	0.000408	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCZ—hematologic cancer	2.38e-05	0.000405	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMMR—hematologic cancer	2.34e-05	0.000399	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—IDH2—hematologic cancer	2.34e-05	0.000399	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	2.32e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CG—hematologic cancer	2.32e-05	0.000396	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PARP1—hematologic cancer	2.29e-05	0.000391	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.27e-05	0.000387	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FBXW7—hematologic cancer	2.26e-05	0.000385	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PARP1—hematologic cancer	2.24e-05	0.000383	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HDAC2—hematologic cancer	2.21e-05	0.000377	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	2.21e-05	0.000377	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	2.21e-05	0.000376	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ARNTL—hematologic cancer	2.2e-05	0.000375	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	2.17e-05	0.000369	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	2.17e-05	0.000369	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CBL—hematologic cancer	2.16e-05	0.000368	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CA9—hematologic cancer	2.14e-05	0.000365	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ACP5—hematologic cancer	2.14e-05	0.000365	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL3—hematologic cancer	2.13e-05	0.000364	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOR2—hematologic cancer	2.11e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CBL—hematologic cancer	2.11e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	2.11e-05	0.00036	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	2.1e-05	0.000358	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL3—hematologic cancer	2.09e-05	0.000356	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	2.07e-05	0.000353	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	2.06e-05	0.000352	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	2.06e-05	0.000352	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	2.06e-05	0.000351	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SYK—hematologic cancer	2.06e-05	0.000351	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	2.05e-05	0.00035	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	2.04e-05	0.000348	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	2.03e-05	0.000346	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	2.02e-05	0.000344	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	2.01e-05	0.000343	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SYK—hematologic cancer	2.01e-05	0.000343	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—IDH1—hematologic cancer	2.01e-05	0.000343	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	2.01e-05	0.000342	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	2e-05	0.00034	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.99e-05	0.000339	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.99e-05	0.000339	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TXN—hematologic cancer	1.99e-05	0.000339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	1.98e-05	0.000338	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	1.96e-05	0.000335	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	1.96e-05	0.000335	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	1.96e-05	0.000334	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.95e-05	0.000332	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	1.94e-05	0.000331	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.93e-05	0.000329	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	1.92e-05	0.000328	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	1.92e-05	0.000327	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	1.89e-05	0.000322	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	1.87e-05	0.000319	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.87e-05	0.000319	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	1.87e-05	0.000318	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	1.86e-05	0.000317	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	1.85e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	1.85e-05	0.000316	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	1.83e-05	0.000312	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	1.83e-05	0.000311	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	1.83e-05	0.000311	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.82e-05	0.00031	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.82e-05	0.00031	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	1.82e-05	0.00031	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	1.81e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	1.81e-05	0.000309	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	1.79e-05	0.000304	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	1.78e-05	0.000304	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.78e-05	0.000303	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.77e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	1.77e-05	0.000302	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	1.75e-05	0.000298	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	1.75e-05	0.000298	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	1.74e-05	0.000297	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	1.73e-05	0.000295	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NUP98—hematologic cancer	1.72e-05	0.000293	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	1.71e-05	0.000292	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	1.71e-05	0.000292	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	1.7e-05	0.00029	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	1.69e-05	0.000288	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	1.68e-05	0.000286	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	1.67e-05	0.000285	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.67e-05	0.000284	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.67e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	1.66e-05	0.000284	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	1.66e-05	0.000283	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	1.66e-05	0.000283	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NUP214—hematologic cancer	1.66e-05	0.000282	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	1.65e-05	0.000281	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	1.64e-05	0.00028	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	1.63e-05	0.000279	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	1.63e-05	0.000279	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	1.63e-05	0.000278	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	1.62e-05	0.000277	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	1.62e-05	0.000277	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTR—hematologic cancer	1.62e-05	0.000277	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.62e-05	0.000277	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	1.62e-05	0.000276	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	1.61e-05	0.000274	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	1.6e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	1.6e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	1.6e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	1.6e-05	0.000273	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	1.6e-05	0.000272	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ENO2—hematologic cancer	1.59e-05	0.000271	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	1.58e-05	0.00027	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	1.57e-05	0.000268	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	1.57e-05	0.000267	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	1.57e-05	0.000267	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.54e-05	0.000263	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SDC1—hematologic cancer	1.51e-05	0.000257	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	1.5e-05	0.000255	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	1.48e-05	0.000253	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	1.48e-05	0.000252	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	1.46e-05	0.000249	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	1.45e-05	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	1.45e-05	0.000247	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	1.44e-05	0.000246	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	1.41e-05	0.000241	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	1.41e-05	0.00024	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	1.38e-05	0.000235	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	1.36e-05	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	1.34e-05	0.000229	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	1.33e-05	0.000226	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	1.32e-05	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	1.31e-05	0.000224	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	1.3e-05	0.000222	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	1.29e-05	0.00022	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	1.29e-05	0.000219	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	1.29e-05	0.000219	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD44—hematologic cancer	1.28e-05	0.000219	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NQO1—hematologic cancer	1.28e-05	0.000219	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	1.27e-05	0.000217	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	1.27e-05	0.000217	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	1.26e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	1.26e-05	0.000215	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	1.25e-05	0.000213	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	1.25e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	1.25e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	1.25e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	1.25e-05	0.000212	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	1.22e-05	0.000209	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	1.22e-05	0.000208	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYCS—hematologic cancer	1.21e-05	0.000207	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.21e-05	0.000206	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	1.2e-05	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	1.19e-05	0.000203	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	1.19e-05	0.000202	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	1.17e-05	0.0002	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	1.17e-05	0.000199	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	1.16e-05	0.000198	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	1.16e-05	0.000198	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	1.16e-05	0.000197	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	1.15e-05	0.000197	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	1.15e-05	0.000195	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	1.13e-05	0.000194	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	1.13e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	1.13e-05	0.000193	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	1.1e-05	0.000188	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	1.09e-05	0.000187	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.08e-05	0.000185	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	1.08e-05	0.000184	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	1.07e-05	0.000183	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	1.07e-05	0.000183	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.07e-05	0.000182	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.06e-05	0.000181	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	1.05e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	1.05e-05	0.000179	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	1.03e-05	0.000176	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	1.03e-05	0.000175	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.01e-05	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	1.01e-05	0.000172	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	1e-05	0.000171	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	9.85e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	9.83e-06	0.000168	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—hematologic cancer	9.83e-06	0.000168	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NCOR1—hematologic cancer	9.83e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	9.81e-06	0.000167	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	9.63e-06	0.000164	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	9.6e-06	0.000164	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	9.54e-06	0.000163	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	9.54e-06	0.000163	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	9.34e-06	0.000159	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	9.34e-06	0.000159	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	9.11e-06	0.000155	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	8.96e-06	0.000153	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	8.91e-06	0.000152	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	8.86e-06	0.000151	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	8.78e-06	0.00015	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	8.76e-06	0.000149	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	8.76e-06	0.000149	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	8.72e-06	0.000149	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—hematologic cancer	8.68e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	8.67e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	8.59e-06	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	8.57e-06	0.000146	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	8.54e-06	0.000146	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	8.53e-06	0.000145	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	8.53e-06	0.000145	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	8.36e-06	0.000143	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	8.34e-06	0.000142	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	8.27e-06	0.000141	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	8.25e-06	0.000141	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	8.09e-06	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	8.07e-06	0.000138	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	8.07e-06	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	8.05e-06	0.000137	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	7.89e-06	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	7.87e-06	0.000134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	7.86e-06	0.000134	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	7.69e-06	0.000131	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	7.65e-06	0.00013	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	7.48e-06	0.000128	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	7.45e-06	0.000127	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	7.38e-06	0.000126	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	7.36e-06	0.000125	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CG—hematologic cancer	7.3e-06	0.000124	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	7.29e-06	0.000124	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	7.21e-06	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	7.2e-06	0.000123	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	7.05e-06	0.00012	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	6.89e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	6.85e-06	0.000117	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	6.84e-06	0.000117	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CREBBP—hematologic cancer	6.77e-06	0.000115	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	6.7e-06	0.000114	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	6.69e-06	0.000114	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.41e-06	0.000109	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	6.33e-06	0.000108	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—hematologic cancer	6.33e-06	0.000108	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	6.19e-06	0.000106	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3R1—hematologic cancer	6.06e-06	0.000103	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	5.82e-06	9.92e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	5.69e-06	9.71e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	5.63e-06	9.6e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.59e-06	9.53e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	5.51e-06	9.39e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	5.38e-06	9.18e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	5.27e-06	8.98e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	5.15e-06	8.79e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	5.04e-06	8.59e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTEN—hematologic cancer	4.83e-06	8.24e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	4.75e-06	8.1e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	4.65e-06	7.93e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—EP300—hematologic cancer	4.61e-06	7.86e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.41e-06	5.81e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—hematologic cancer	2.78e-06	4.75e-05	CbGpPWpGaD
